Literature DB >> 24839528

Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells.

Sanna E Herwald1, Carol A Kumamoto2.   

Abstract

The fungus Candida albicans is a frequent commensal colonizer of the human gastrointestinal (GI) tract, but is also an opportunistic pathogen. This review explores features that distinguish the colonizing and pathogenic forms of C. albicans. Candida albicans in a biofilm is used as an example of a pathogenic form of the organism, because biofilms are a common feature of device-associated C. albicans infections. Biofilms (complex, sessile communities of cells) have been the subject of several large-scale gene expression studies. Biofilms and commensal C. albicans colonizing the murine GI tract show a variety of differentially expressed genes. Cell surface proteins encoded by these differentially expressed genes are especially attractive as targets for new clinical prevention, diagnosis, or treatment tools that are specific for C. albicans in its pathogenic biofilm state.

Entities:  

Keywords:  Biofilm; Candida albicans; Cell surface; Commensal; Gastrointestinal; Gene expression; Pathogenesis

Year:  2014        PMID: 24839528      PMCID: PMC4019406          DOI: 10.1007/s12281-014-0178-x

Source DB:  PubMed          Journal:  Curr Fungal Infect Rep        ISSN: 1936-3761


  60 in total

1.  Genetic control of Candida albicans biofilm development.

Authors:  Jonathan S Finkel; Aaron P Mitchell
Journal:  Nat Rev Microbiol       Date:  2010-12-29       Impact factor: 60.633

2.  Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis.

Authors:  T Mio; M Adachi-Shimizu; Y Tachibana; H Tabuchi; S B Inoue; T Yabe; T Yamada-Okabe; M Arisawa; T Watanabe; H Yamada-Okabe
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

Review 3.  Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders.

Authors:  Antonio Cassone; Roberto Cauda
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

Review 4.  Th17 cells in immunity to Candida albicans.

Authors:  Nydiaris Hernández-Santos; Sarah L Gaffen
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

5.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

6.  Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns.

Authors:  Susana García-Sánchez; Sylvie Aubert; Ismaïl Iraqui; Guilhem Janbon; Jean-Marc Ghigo; Christophe d'Enfert
Journal:  Eukaryot Cell       Date:  2004-04

Review 7.  Antifungal lock therapy.

Authors:  Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

8.  Experimental biofilm-related Candida infections.

Authors:  Daniela Cirasola; Rita Sciota; Loredana Vizzini; Valentina Ricucci; Giulia Morace; Elisa Borghi
Journal:  Future Microbiol       Date:  2013-06       Impact factor: 3.165

Review 9.  Yeasts in the gut: from commensals to infectious agents.

Authors:  Jürgen Schulze; Ulrich Sonnenborn
Journal:  Dtsch Arztebl Int       Date:  2009-12-18       Impact factor: 5.594

Review 10.  Recent insights into Candida albicans biofilm resistance mechanisms.

Authors:  Lotte Mathé; Patrick Van Dijck
Journal:  Curr Genet       Date:  2013-08-25       Impact factor: 3.886

View more
  6 in total

1.  Partridge and embryonated partridge egg as new preclinical models for candidiasis.

Authors:  Hadi Tavakkoli; Ahmad Khosravi; Iraj Sharifi; Zohreh Salari; Ehsan Salarkia; Reza Kheirandish; Kazem Dehghantalebi; Maziar Jajarmi; Seyedeh Saedeh Mosallanejad; Shahriar Dabiri; Alireza Keyhani
Journal:  Sci Rep       Date:  2021-01-22       Impact factor: 4.379

Review 2.  Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.

Authors:  Matheus Aparecido Dos Santos Ramos; Patrícia Bento Da Silva; Larissa Spósito; Luciani Gaspar De Toledo; Bruna Vidal Bonifácio; Camila Fernanda Rodero; Karen Cristina Dos Santos; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2018-02-27

3.  Upregulation of secreted aspartyl proteinase genes of fluconazole-sensitive Candida albicans isolates.

Authors:  Carolina do Rosário Esteves Guimarães; Humberto Fonseca de Freitas; Tânia Fraga Barros
Journal:  Mol Biol Rep       Date:  2019-10-10       Impact factor: 2.316

4.  Synergism Effect of the Essential Oil from Ocimum basilicum var. Maria Bonita and Its Major Components with Fluconazole and Its Influence on Ergosterol Biosynthesis.

Authors:  Nathalia N R Cardoso; Celuta S Alviano; Arie F Blank; Maria Teresa V Romanos; Beatriz B Fonseca; Sonia Rozental; Igor A Rodrigues; Daniela S Alviano
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-05       Impact factor: 2.629

5.  Efflux pump-mediated resistance to antifungal compounds can be prevented by conjugation with triphenylphosphonium cation.

Authors:  Wenqiang Chang; Jun Liu; Ming Zhang; Hongzhuo Shi; Sha Zheng; Xueyang Jin; Yanhui Gao; Shuqi Wang; Aiguo Ji; Hongxiang Lou
Journal:  Nat Commun       Date:  2018-11-30       Impact factor: 14.919

Review 6.  Vaccines for human fungal diseases: close but still a long way to go.

Authors:  Lorena V N Oliveira; Ruiying Wang; Charles A Specht; Stuart M Levitz
Journal:  NPJ Vaccines       Date:  2021-03-03       Impact factor: 7.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.